๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men

โœ Scribed by James B. Meigs; Beth Mohr; Michael J. Barry; Mary McNaughton Collins; John B. McKinlay


Book ID
117596972
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
79 KB
Volume
54
Category
Article
ISSN
0895-4356

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Prostate carcinoma risk subsequent to di
โœ Anand P. Chokkalingam; Olof Nyrรฉn; Jan-Erik Johansson; Gloria Gridley; Joseph K. ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 91 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND Pathologically, benign prostatic hyperplasia (BPH) is not considered a precursor for prostate carcinoma. However, because the two conditions share not only a similar hormonal environment within the prostate but also several common risk factors, it is possible that men wit

CYP17 polymorphisms in relation to risks
โœ M. Patricia Madigan; Yu-Tang Gao; Jie Deng; Ruth M. Pfeiffer; Bao-Li Chang; Siqu ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 78 KB ๐Ÿ‘ 1 views

## Abstract Because androgens likely play a key role in prostate growth and prostate cancer development, variants of genes involved in androgen biosynthesis may be related to prostate cancer risk. The enzyme P450c17ฮฑ, encoded by the __CYP17__ gene, catalyzes the conversion of progesterone and pregn